FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagetest.fhir.onc.ctm
Resource TypeMedicationAdministration
IdMedicationAdministration-cancer-related-medication-admin-cyclophosphamide-jenny-m.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

No narrative content found in resource


Source1

{
  "resourceType": "MedicationAdministration",
  "id": "cancer-related-medication-admin-cyclophosphamide-jenny-m",
  "meta": {
    "profile": [
      "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent",
      "valueCodeableConcept": {
        "coding": [
          {
            "code": "373808002",
            "system": "http://snomed.info/sct",
            "display": "Curative - procedure intent (qualifier value)"
          }
        ]
      }
    }
  ],
  "status": "completed",
  "category": {
    "coding": [
      {
        "code": "outpatient",
        "system": "http://terminology.hl7.org/CodeSystem/medicationrequest-category"
      }
    ]
  },
  "medicationCodeableConcept": {
    "coding": [
      {
        "code": "3002",
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "display": "cyclophosphamide"
      }
    ]
  },
  "subject": {
    "reference": "Patient/cancer-patient-jenny-m"
  },
  "effectiveDateTime": "2018-04-22",
  "performer": [
    {
      "actor": {
        "reference": "Practitioner/us-core-practitioner-nancy-oncology-nurse"
      }
    }
  ],
  "reasonReference": [
    {
      "reference": "Condition/primary-cancer-condition-jenny-m"
    }
  ],
  "note": [
    {
      "authorReference": {
        "reference": "Practitioner/us-core-practitioner-nancy-oncology-nurse"
      },
      "time": "2018-04-22",
      "text": "cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects."
    }
  ],
  "dosage": {
    "route": {
      "coding": [
        {
          "code": "47625008",
          "system": "http://snomed.info/sct",
          "display": "Intravenous route (qualifier value)"
        }
      ]
    },
    "dose": {
      "value": 932.59,
      "code": "mg",
      "system": "http://unitsofmeasure.org",
      "unit": "mg"
    }
  }
}